TEXT-EXTRACT 2 filename2.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE April 4, 2019 By E-Mail Andrew M. Freedman, Esq. Olshan Frome Wolosky LLP 1325 Avenue of the Americas New York, NY 10019 Re: Gannett Co., Inc. Definitive Additional Materials on Schedule 14A filed by MNG Enterprises, Inc., et. al. Filed on April 2, 2019 File No. 001-36874 Dear Mr. Freedman: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Definitive Additional Soliciting Materials Item 1. Press Release dated April 2, 2019 1. We note your references to historical financial results without the clarification you made in your proxy statement in response to comment 6 in our March 21, 2019 letter. Please revise. 2. Each statement or assertion of opinion or belief must be clearly characterized as such, and a reasonable factual basis must exist for each such opinion or belief. Support for opinions or beliefs should be self-evident, disclosed in the proxy statement or provided to the staff on a supplemental basis. With a view toward revised disclosure, provide support for your statement that you are offering "speed and certainty" in connection with your offer. 3. With a view toward revised disclosure, state whether Oaktree is willing to finance your offer, in part or in full, or whether Oaktree is solely evaluating your credit worthiness for purposes of the proposed transaction. 4. We note your references to the Gannett board as "delusional" and to Gannett offering "just a bunch of misleading statistics." Note that you must avoid issuing statements that directly or indirectly impugn the character, integrity or personal reputation or make charges of illegal, improper or immoral conduct without factual foundation. Provide us supplementally, or disclose, the factual foundation for the assertion referenced above. In Andrew M. Freedman Olshan Frome Wolosky LLP April 4, 2019 Page 2 this regard, note that the factual foundation for such assertion must be reasonable. Refer to Rule 14a-9. 5. We note your disclosure that "Not voting is the same as voting against the transaction." Please revise your disclosure to clarify it. For example, explain (i) why a vote on the election of directors is related to a vote on a proposed transaction, and (ii) given the plurality voting standard applicable to the upcoming election of directors, how not voting will have an impact on the election of directors. Please direct any questions to me at (202) 551-3619. Sincerely, /s/ Daniel F. Duchovny Daniel F. Duchovny Special Counsel Office of Mergers and Acquisitions